The Pharmaceutical Contract Manufacturing Services industry on FinBizNet covers 26 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 26 |
|---|---|
| Combined market cap | ₹2,35,964 Cr |
| Median P/E (profitable companies) | 36.4 |
| Median return on equity | 4.4% |
| Companies with latest quarterly results | 13 of 26 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,79,494 Cr | 73.6 | 17.0% | ₹4,979 Cr | ₹534 Cr | Q2 FY27 |
| Aether Industries Limited | ₹21,710 Cr | 101.8 | 9.8% | ₹347 Cr | ₹68 Cr | Q2 FY27 |
| Alivus Life Sciences Ltd | ₹17,862 Cr | 31.5 | 18.4% | ₹682 Cr | ₹197 Cr | Q2 FY27 |
| Aarti Pharmalabs Ltd | ₹8,374 Cr | 52.5 | 8.5% | ₹610 Cr | ₹71 Cr | Q2 FY27 |
| Solara Active Pharma Sciences Limited | ₹3,225 Cr | — | -0.6% | ₹417 Cr | ₹28 Cr | Q2 FY27 |
| Sai Parenteral's Limited | ₹2,235 Cr | 115.8 | 2.9% | ₹195 Cr | ₹11 Cr | Q2 FY27 |
| KRM Ayurveda Limited | ₹521 Cr | 25.9 | 17.5% | ₹32 Cr | ₹9 Cr | Q1 FY27 |
| Trident Lifeline Limited | ₹511 Cr | 26.0 | — | — | — | — |
| Infinium Pharmachem Limited | ₹436 Cr | 36.4 | 10.5% | — | — | — |
| Accretion Nutraveda Limited | ₹256 Cr | 37.7 | — | — | — | — |
| Sanjivani Paranteral Ltd. | ₹212 Cr | 31.1 | 14.8% | ₹19 Cr | ₹2 Cr | Q1 FY27 |
| Bio Medica Laboratories Limited | ₹188 Cr | 11.5 | 44.4% | — | — | — |
| Quest Laboratories Limited | ₹147 Cr | 10.2 | 16.8% | ₹32 Cr | ₹3 Cr | Q4 FY26 |
| Curis Lifesciences Limited | ₹138 Cr | — | 14.6% | — | — | — |
| Pharmaids Pharmaceuticals Ltdte | ₹105 Cr | — | -17.8% | ₹0 Cr | ₹2 Cr | Q1 FY27 |
| Cian Healthcare Ltd | ₹98 Cr | — | -57.3% | — | — | — |
| Concord Drugs Ltd | ₹96 Cr | 77.7 | 2.6% | — | — | — |
| Denis Chem Lab Ltd | ₹87 Cr | — | — | ₹44 Cr | ₹2 Cr | Q1 FY27 |
| Rekvina Laboratories Ltd | ₹79 Cr | — | — | — | — | — |
| Onyx Biotec Limited | ₹65 Cr | — | -0.4% | — | — | — |
| Vivimed Labs Ltd. | ₹45 Cr | — | — | ₹12 Cr | ₹-146 Cr | Q4 FY26 |
| Medicamen Organics Limited | ₹30 Cr | — | -13.7% | — | — | — |
| Zenith Healthcare Ltd | ₹18 Cr | 3450.0 | 0.1% | ₹3 Cr | ₹0 Cr | Q1 FY27 |
| Norris Medicines Ltd. | ₹14 Cr | — | 1.9% | — | — | — |
| Beryl Drugs Ltd. | ₹12 Cr | 28.7 | 4.4% | — | — | — |
| Evoq Remedies Ltd | ₹4 Cr | — | -0.5% | — | — | — |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 26 listed companies in the Pharmaceutical Contract Manufacturing Services industry, including Torrent Pharma Ltd., Aether Industries Limited, Alivus Life Sciences Ltd, Aarti Pharmalabs Ltd, Solara Active Pharma Sciences Limited, Sai Parenteral's Limited, KRM Ayurveda Limited, Trident Lifeline Limited, among others.
By market capitalisation, the largest Pharmaceutical Contract Manufacturing Services companies are Torrent Pharma Ltd. (₹1,79,494 Cr), Aether Industries Limited (₹21,710 Cr), Alivus Life Sciences Ltd (₹17,862 Cr), Aarti Pharmalabs Ltd (₹8,374 Cr), Solara Active Pharma Sciences Limited (₹3,225 Cr).
The 26 Pharmaceutical Contract Manufacturing Services companies tracked on FinBizNet have a combined market capitalisation of about ₹2,35,964 Cr.
The median price-to-earnings ratio across 15 profitable Pharmaceutical Contract Manufacturing Services companies is 36.4, and the median return on equity across the industry is 4.4%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Pharmaceutical Contract Manufacturing Services industry.